evertex fabrinology limited reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 115.04 million compared to TWD 166.28 million a year ago. Revenue was TWD 145.55 million compared to TWD 226.37 million a year ago. Net income was TWD 5.49 million compared to TWD 12.61 million a year ago. Basic earnings per share from continuing operations was TWD 0.06 compared to TWD 0.15 a year ago. Diluted earnings per share from continuing operations was TWD 0.06 compared to TWD 0.15 a year ago.
For the nine months, sales was TWD 414.86 million compared to TWD 548.89 million a year ago. Revenue was TWD 527.02 million compared to TWD 735.6 million a year ago. Net income was TWD 49.3 million compared to TWD 33.43 million a year ago. Basic earnings per share from continuing operations was TWD 0.57 compared to TWD 0.39 a year ago. Diluted earnings per share from continuing operations was TWD 0.57 compared to TWD 0.39 a year ago.